USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$39.50 USD
+0.10 (0.25%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $39.46 -0.04 (-0.10%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$39.50 USD
+0.10 (0.25%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $39.46 -0.04 (-0.10%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth B Momentum A VGM
Zacks News
Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Pick USANA Health (USNA) Stock Now?
by Zacks Equity Research
Is USANA Health Sciences (USNA) a great pick from the value investor's perspective right now? Read on to know more.
Jazz Pharma (JAZZ) Beats on Q3 Earnings, Ups Sales Guidance
by Zacks Equity Research
Jazz Pharmaceuticals (JAZZ) reports better-than-expected third-quarter 2020 earnings and revenues and ups its sales guidance for 2020.
Is USANA Health Sciences (USNA) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (USNA) Outperforming Other Medical Stocks This Year?
USANA Health Sciences (USNA) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
USANA Health (USNA) delivered earnings and revenue surprises of 11.63% and 5.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
USANA Health Sciences (USNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 DuPont-Rich Quality Picks to Handle Sudden Sell-Off
by Sanghamitra Saha
Why you should depend on the DuPont technique to pick solid profit-generating stocks.
Zacks.com featured highlights include: MED, SYX, USNA, HUM and XPEL
by Zacks Equity Research
Zacks.com featured highlights include: MED, SYX, USNA, HUM and XPEL
Play DuPont Technique to Bet on 5 Top-Ranked Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (USNA) Outperforming Other Medical Stocks This Year?
Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System
6 Must-Buy Quality Stocks Screened on DuPont Analysis
by Sanghamitra Saha
Bet on six top-ranked stocks with higher ROE derived the DuPont way.
Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (USNA) Outperforming Other Medical Stocks This Year?
USANA Health Sciences (USNA) Tops Q2 Earnings Estimates
by Zacks Equity Research
USANA Health (USNA) delivered earnings and revenue surprises of 10.92% and -3.29%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
Zoetis (ZTS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top Ranked Momentum Stocks to Buy for July 21st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 21st
Explore 5 Top-Ranked Stocks Through DuPont Analysis
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
USANA (USNA) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
USANA (USNA) will release second-quarter 2020 results, which are likely to reflect impacts of the COVID-19 pandemic.
Will USANA Health Sciences Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor of USANA Health Sciences
New Strong Buy Stocks For July 17th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (USNA) Outperforming Other Medical Stocks This Year?
USANA Health Sciences (USNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AbbVie (ABBV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 DuPont-Tested Winning Stocks
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks.